Takeda's leuprorelin successor moves into Phase II in Japan
30 August 2011
Ian Haydock
Please Login to read the full article.
30 August 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- New formulation of Abbott's Lupron Depot receives US FDA approval
- FDA lifts clinical hold on GTx' Capesaris prostate cancer drug
- Degarelix and iguratimod in latest batch of Japanese recommendations
- GTx raises $47.5 M to advance Ostarine in cancer-wasting and partner Capesaris
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
